Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Attention-deficit hyperactivity disorder: the pharmacist's role

G M Levin1

  • 1Albany College of Pharmacy, Union University, NY, USA.

American Pharmacy
|November 1, 1995
PubMed
Summary

Pharmacists play a key role in managing attention deficit hyperactivity disorder (ADHD) pharmacotherapy by counseling patients on various medication classes, including stimulants, TCAs, bupropion, clonidine, and MAOIs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparison of patient-rated burden and incidence of side-effects: lithium versus valproate.

International journal of psychiatry in clinical practice·2014
Same author

Long-term effects of maternal separation on chronic stress response suppressed by amitriptyline treatment.

Stress (Amsterdam, Netherlands)·2013
Same author

Methamphetamine and fluoxetine treatment of a child with attention-deficit hyperactivity disorder and obsessive-compulsive disorder.

Journal of child and adolescent psychopharmacology·2009
Same author

Case report: development of precocious puberty in two children treated with clonidine for aggressive behavior.

Journal of child and adolescent psychopharmacology·2009
Same author

Venlafaxine induces P-glycoprotein in human Caco-2 cells.

Human psychopharmacology·2006
Same author

Sex differences in rats: effects of chronic stress on sympathetic system and anxiety.

Physiology & behavior·2005

Area of Science:

  • Pharmacology
  • Neuroscience
  • Clinical Pharmacy

Background:

  • Attention deficit hyperactivity disorder (ADHD) requires pharmacologic management with various drug classes.
  • Pharmacists are accessible healthcare professionals crucial for patient and family counseling.
  • Understanding drug side effects and monitoring parameters is essential for effective ADHD treatment.

Purpose of the Study:

  • To review pharmacologic options for ADHD treatment.
  • To highlight the pharmacist's role in patient support and education.
  • To discuss the efficacy, side effects, and monitoring of different ADHD medication classes.

Main Methods:

  • Review of pharmacologic agents used for ADHD treatment.
  • Categorization of medications into stimulants, TCAs, bupropion, clonidine, and MAOIs.
  • Discussion of counseling points for pharmacists.

Main Results:

  • Stimulants (amphetamines, methylphenidate) are most effective for ADHD.
  • Second-line agents include TCAs (imipramine), bupropion, and clonidine, with varying efficacy and side effect profiles.
  • MAOIs are considered agents of last resort.

Conclusions:

  • No ideal ADHD medication currently exists, necessitating trial-and-error approaches.
  • Pharmacists are vital in guiding patients through medication selection and management.
  • Further research is needed to identify optimal ADHD treatments with improved profiles.

Related Experiment Videos